Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Operating Margin: 2010-2016

Historic Operating Margin for Tenax Therapeutics (TENX) over the last 2 years, with Dec 2016 value amounting to -2,801,940.35%.

  • Tenax Therapeutics' Operating Margin was N/A to -2,801,940.35% in Q4 2016 from the same period last year, while for Dec 2016 it was -3,418.54%, marking a year-over-year change of. This contributed to the annual value of 84,756.52% for FY2024, which is 5044819.00% up from last year.
  • According to the latest figures from Q4 2016, Tenax Therapeutics' Operating Margin is -2,801,940.35%, which was down 62,937.55% from -4,444.87% recorded in Q2 2013.
  • Tenax Therapeutics' Operating Margin's 5-year high stood at -132.62% during Q4 2012, with a 5-year trough of -2,801,940.35% in Q4 2016.
  • Over the past 1 years, Tenax Therapeutics' median Operating Margin value was -2,801,940.35% (recorded in 2016), while the average stood at -2,801,940.35%.
  • Within the past 5 years, the most significant YoY rise in Tenax Therapeutics' Operating Margin was 914,614bps (2012), while the steepest drop was 1,162,433bps (2012).
  • Over the past 3 years, Tenax Therapeutics' Operating Margin (Quarterly) stood at -132.62% in 2012, then plummeted by 249,266bps to -4,444.87% in 2013, then reached -2,801,940.35% in 2016.
  • Its last three reported values are -2,801,940.35% in Q4 2016, -4,444.87% for Q2 2013, and -715.64% during Q1 2013.